GLP1R and type 2 diabetes mellitus: [4] have used a combination of complementary experimental designs and approaches. This includes the exploration of the Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) databases for tumour-specific and normal tissue-specific expression analyses of PSMA2, expression analyses of PSMA2 and GLP-1R levels in cervical specimens from patients with and without T2D, and subsequent validation of the results in vivo using preclinical mouse models and in vitro using cervical cancer cell models.